4.8 Article

Targeting mitochondria metabolism for cancer therapy

Journal

NATURE CHEMICAL BIOLOGY
Volume 11, Issue 1, Pages 9-15

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nchembio.1712

Keywords

-

Funding

  1. US National Institutes of Health [R01CA123067, 5T32HL076139-10]
  2. NATIONAL CANCER INSTITUTE [R01CA123067] Funding Source: NIH RePORTER
  3. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Mitochondria have a well-recognized role in the production of ATP and the intermediates needed for macromolecule biosynthesis, such as nucleotides. Mitochondria also participate in the activation of signaling pathways. Overall, accumulating evidence now suggests that mitochondrial bioenergetics, biosynthesis and signaling are required for tumorigenesis. Thus, emerging studies have begun to demonstrate that mitochondrial metabolism is potentially a fruitful arena for cancer therapy. In this Perspective, we highlight recent developments in targeting mitochondrial metabolism for the treatment of cancer. npg (C) 2015 Nature America, Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available